Laboratorios Farmaceuticos Financials

Laboratorios Farmaceuticos Stock Summary

Laboratorios Farmaceuticos competes with ALK-Abelló A/S, Genscript Biotech, Shanghai Junshi, Camurus AB, and InnoCare Pharma. Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Laboratorios Farmaceuticos operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1852 people.

Laboratorios Farmaceuticos Key Financial Ratios

There are many critical financial ratios that Laboratorios Farmaceuticos' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Laboratorios Farmaceuticos reports annually and quarterly.

Laboratorios Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Farmaceuticos's current stock value. Our valuation model uses many indicators to compare Laboratorios Farmaceuticos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Farmaceuticos competition to find correlations between indicators driving Laboratorios Farmaceuticos's intrinsic value. More Info.Laboratorios Farmaceuticos Rovi is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about  0.47  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratorios Farmaceuticos Rovi is roughly  2.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratorios Farmaceuticos' earnings, one of the primary drivers of an investment's value.

When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.